OSM, an IL-6 family cytokine in inducing mesenchymal properties in GBM which mediated signaling contributes to aggressive nature associated with mesenchymal features via STAT3 signaling in glioma cells [20]). The gene discussed is IL6; the disease is central nervous system cancer.